This study was supported by a Wellcome Trust-NIH PhD Studentship to SB, WDF and NV. Grant number 098252/Z/12/Z. SB, CHC and WDF are supported by the Intramural Research Program, NCI, NIH. NHG and WL are supported by the Intramural Research Program, NIA, NIH.Peer reviewedPublisher PD
Apologies to the many papers we were unable to cite, due to space constraints. We thank Lynda Erskin...
Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characteriz...
Over 80,000 synthetic chemicals are currently in commercial use without a full assessment of their a...
This study was supported by a Wellcome Trust-NIH PhD Studentship to SB, WDF and NV. Grant number 098...
The authors thank Scott McMenemy for carrying out preliminary, early studies looking at effects of G...
Shaunna Beedie is a recipient of a Wellcome Trust-NIH PhD Studentship (Grant number 098252/Z/12/Z). ...
Acknowledgements The authors would like to thank Maria Kisakyamaria and Scott McMenemy for prelimina...
Angiogenesis is a crucial event for tumor progression and metastasis. It is the process through whic...
Thalidomide and its analog, Lenalidomide, are in current use clinically for treatment of multiple my...
Their optical clarity as larvae and embryos, small size, and high fecundity make zebrafish ideal for...
Funding: This research was supported in part by the Intramural Research Program of the Center for Ca...
Discovering novel compounds that stimulate or abrogate angiogenesis can lead to development of new t...
AbstractInhibition of angiogenesis is currently perceived as a promising strategy in the treatment o...
Angiogenesis is a crucial event for tumor progression and metastasis. It is the process through whic...
AbstractThalidomide has reemerged as a promising anticancer and anti-inflammatory drug despite its d...
Apologies to the many papers we were unable to cite, due to space constraints. We thank Lynda Erskin...
Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characteriz...
Over 80,000 synthetic chemicals are currently in commercial use without a full assessment of their a...
This study was supported by a Wellcome Trust-NIH PhD Studentship to SB, WDF and NV. Grant number 098...
The authors thank Scott McMenemy for carrying out preliminary, early studies looking at effects of G...
Shaunna Beedie is a recipient of a Wellcome Trust-NIH PhD Studentship (Grant number 098252/Z/12/Z). ...
Acknowledgements The authors would like to thank Maria Kisakyamaria and Scott McMenemy for prelimina...
Angiogenesis is a crucial event for tumor progression and metastasis. It is the process through whic...
Thalidomide and its analog, Lenalidomide, are in current use clinically for treatment of multiple my...
Their optical clarity as larvae and embryos, small size, and high fecundity make zebrafish ideal for...
Funding: This research was supported in part by the Intramural Research Program of the Center for Ca...
Discovering novel compounds that stimulate or abrogate angiogenesis can lead to development of new t...
AbstractInhibition of angiogenesis is currently perceived as a promising strategy in the treatment o...
Angiogenesis is a crucial event for tumor progression and metastasis. It is the process through whic...
AbstractThalidomide has reemerged as a promising anticancer and anti-inflammatory drug despite its d...
Apologies to the many papers we were unable to cite, due to space constraints. We thank Lynda Erskin...
Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characteriz...
Over 80,000 synthetic chemicals are currently in commercial use without a full assessment of their a...